We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Search

Press to close the select your country window or navigate to it's content

Find more information about Teva in your location, or contact a local representative on our local sites

North America

Canada
United States

International Markets

Argentina
Australia
Belarus
Brazil
Chile
China
Hong Kong SAR
India
Indonesia
Israel
Japan
Kazakhstan
Kyrgyzstan
Mexico
New Zealand
Peru
Russia
Singapore
South Africa
South Korea
Thailand
Turkey
Ukraine
Uruguay

Europe

North America

Canada
United States

International Markets

Argentina
Australia
Belarus
Brazil
Chile
China
Hong Kong SAR
India
Indonesia
Israel
Japan
Kazakhstan
Kyrgyzstan
Mexico
New Zealand
Peru
Russia
Singapore
South Africa
South Korea
Thailand
Turkey
Ukraine
Uruguay

Europe

Investors
News & Media

Our Company Show Submenu
As a global leader in generic medicines with a strong innovative portfolio, we are all in for better health.
Product Focus Show Submenu
Quality, accessibility, and innovation, without compromise
Patients & Caregivers Show Submenu
Our Impact Show Submenu
Acting responsibly and ethically in all we do helps ensure our sustainability—allowing Teva to provide treatments to those who need them for years to come.
Your Career Show Submenu
Working at Teva is not just a job, it’s so much more than that. Here, you get to spend each day helping millions of people around the world enjoy healthier lives. At the same time, you’ll be joining a dedicated team, united by the strong sense that we’re building something greater than ourselves.
Contact Us

Home
Teva Clinical Trials
Clinical Trials – Results

Clinical Trials & Results

Find a Trial or Results of a Completed Trial

Search

Filter

Reset all filters

Expand All / Collapse All

Health Condition

Absolute Bioavailability

Adenovirus

ALS

Amyotrophic Lateral Sclerosis

Asthma

Asthma | Chronic Obstructive Pulmonary Disease

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

Asthma | Chronic Obstructive Pulmonary Disease (COPD) | Emphysema | Chronic Bronchitis

Asthma | Elevated Blood Eosinophils | Oral Corticosteroid Dependence

Bioavailability and Pharmacokinetics

BiPolar

Cerebral Palsy, Dyskinetic

Chemotherapy-induced Neutropenia

Chorea

Chronic Cluster Headache

Chronic Migraine

Chronic Myeloid Leukemia

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease | COPD

Chronic Pain

Cluster Headache

Cocaine Addiction

Cognitive Impairment

Contraception

Contraception | Female Contraception

COPD

Crohns Disease

Crohn's Disease

Crohn's Disease Colitis, Ulcerative

Dementia | Alzheimer's Disease

DLBCL

Dyskinesias | Parkinson Disease | Movement Disorders

Eosinophilic Asthma

Eosinophils, Asthma

Epilepsy

Episodic Cluster Headache

Episodic Migraine Headache

Exercise-Induced Bronchoconstriction (EIB)

Exercise-induced Bronchospasm

Female, Maleergic Rhinitis

Fibromyalgia

Follicle Development | Ovarian Follicle | Follicle Count | Follicle Size | Oral Contraceptive

Glioblastoma Multiforme

Glioblastoma Multiforme | Anaplastic Astrocytoma|Anaplastic Oligodendroglioma | Anaplastic Mixed Oligoastrocytoma

Growth Hormone Deficiency

Growth Hormone-Deficiency

Healthy

Healthy Participants

Hematologic Malignancies | Solid Tumors

Hemostasis | Oral Contraceptive

Huntington Disease

Huntington's Disease

Interstitial Cystitis

Leukemia

Low Back Pain

Lupus Arthritis

Lupus Nephritis

Migraine

Migraine | Major Depressive Disorder

Migraine Headache

Migraine Prophylaxis

Multiple Sclerosis

Multiple System Atrophy

Narcolepsy

Narcolepsy | Obstructive Sleep Apnea | Shift Work Sleep Disorder

Neoplasms, Unknown Primary

Neutropenia

Nonalcoholic Steatohepatitis | Type 2 Diabetes Mellitus

Non-Hodgkin Lymphoma

Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma

Optic Neuritis

Osteoarthritis of the Knee

Pain

Parkinson's Disease

Parkinson's Disease | Malignant Melanoma

Patient Satisfaction

Perennial Female, Maleergic Rhinitis

Perennial Female, Maleergic Rhinitis (PAR)

Persistent Asthma

Pharmacokinetics

Pharmacokinetics | Pharmacodynamics

Postherpetic Neuralgia

Post-Traumatic Headache

Pregnancy | Contraception

Pregnancy Prevention

Pregnancy Rate | Oocytes

Primary Progressive Multiple Sclerosis

Recurrent Glioblastoma Multiforme

Relapse Remitting Multiple Sclerosis

Relapse-Remitting Multiple Sclerosis

Relapsing Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis

Rheumatoid Arthritis

Rhinitis, Female, Maleergic, Perennial

Schizophrenia

Seasonal Female, Maleergic Rhinitis | Hay Fever

Seasonal Female, Maleergic Rhinitis | Hayfever

Seasonal Female, Maleergic Rhinitis | SAR

Serotonin Syndrome

Solid Tumors

Stable Renal Transplant Recipients

Systemic Lupus Erythematosus

Tardive Dyskinesia

Tourette Syndrome

Study Status

Completed

Terminated

Age group

Adult, Older Adult

Gender

Female, Male

Phase

Phase 1/2

Phase 2

Study Types

Interventional

Showing 3 of 3 Results

All Results

Results per page

Trials Ascending

No results found

Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.

Chronic Myeloid Leukemia
Terminated
Adult, Older Adult
Female, Male
Phase 1/2
Interventional

Study ID: C41443/2057 | 2013-005320-42

cancer icon for clinical trials

Condition(s):: Chronic Myeloid Leukemia
Status:: Terminated
Requirements:: 18 Years and older
Interventions:: Drug: Omacetaxine mepesuccinate

Learn more NCT02078960

Chronic Myeloid Leukemia
Completed
Adult, Older Adult
Female, Male
Phase 2
Interventional

Study ID: CGX-635-CML-202 | 2006-000176-32

cancer icon for clinical trials

Condition(s):: Chronic Myeloid Leukemia
Status:: Completed
Requirements:: 18 Years and older
Interventions:: Drug: Omacetaxine mepesuccinate

Learn more NCT00375219

Chronic Myeloid Leukemia
Completed
Adult, Older Adult
Female, Male
Phase 2
Interventional

Study ID: CGX-635-CML-203 | 2007-001286-15

cancer icon for clinical trials

Condition(s):: Chronic Myeloid Leukemia
Status:: Completed
Requirements:: 18 Years and older
Interventions:: Drug: Omacetaxine mepesuccinate

Learn more NCT00462943

At Teva, we strive to deliver quality medicines to patients around the world with integrity and ethical business practices. What we do is important, but how we do it is just as important. Learn more:

Teva Code of Conduct

Supplier Code of Conduct

Environmental, Social and Governance at Teva

All Corporate Governance & Policy Documents

Contact Us
Terms of Use
Social Media Guidelines
Teva api
Medis

Sitemap
Data Privacy
Pharmacovigilance Privacy Notice
Accessibility Statement
Cookie Settings

Follow us

Facebook
Twitter
Linkedin
Youtube

Copyright © 2023 Teva Pharmaceutical Industries Ltd.

You are about to leave the Teva Pharmaceuticals global website

The website you are about to access may be governed by different regional policies, regulations or advertising codes. Please be sure to read the privacy policy and terms of use of the websites that you visit.

Teva Pharmaceuticals is not responsible for the accuracy or compliance with laws of information on any third party websites.

Do you wish to proceed?

This website does not list all Teva-sponsored clinical trials. If you have a question about Teva clinical trials, please email USMedInfo@tevapharm.com or call 1-888-483-8279.